Sensible Biotechnologies: Funding, Investors & Team (Oct 2026)
Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.
Sensible Biotechnologies has raised $27.0M across 1 funding round on record, the most recent a Series A of $27.0M announced in Oct 2026.
That round is above the $4.1M median round size for United Kingdom companies tracked on FundedIQ over the last two years.
Sensible Biotechnologies Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Sensible Biotechnologies Funding Rounds
Sensible Biotechnologies Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
Sensible Biotechnologies Founders and Leadership Team
Contact details for the Sensible Biotechnologies team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Sensible Biotechnologies Funding in Context
Sensible Biotechnologies' latest round of $27.0M is above the median round in United Kingdom. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sensible Biotechnologies in Artificial Intelligence and Oxford
Companies Similar to Sensible Biotechnologies
Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest…
PlannerPal is an AI-powered enterprise workflow platform automating administrative tasks for UK financial…
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
NOAH is a company in the financial sector that offers software solutions for conducting Bitcoin trading.
Konsileo is a business protection specialist utilizing innovation to engage people and supplant various…
Cori Clinical provides AI software for managing clinical trial documents, automating regulatory workflows,…
Nettle's AI combines information from both inside and outside sources, providing valuable insights to aid in…
Nearhuman builds edge AI safety systems and intelligent computer vision solutions for micromobility vehicles.
Altilium Clean Technology offers transition of energy from fossil-based to zero-carbon by decarbonizing the…
PubX enables publishers to make more money from their programmatic advertising via an AI-powered dynamic…
Comparables.ai provides an AI-augmented company analysis platform for professionals to find and compare…
EyeQuant is a predictive AI that shows how much of user attention is captured by your designs.
Sensible Biotechnologies Funding FAQs
What does Sensible Biotechnologies do?
Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.
How much funding has Sensible Biotechnologies raised?
Sensible Biotechnologies has raised $27.0M across 1 round on record. The most recent is a Series A of $27.0M announced in Oct 2026.
When did Sensible Biotechnologies last raise funding?
Sensible Biotechnologies' most recent funding round on record is a Series A of $27.0M, announced in Oct 2026.
Who has invested in Sensible Biotechnologies?
Investors on record for Sensible Biotechnologies include Y Combinator, OTB Ventures, BACKED VC, BlueYard Capital, KAYA. FundedIQ records 21 investors in total.
Who founded Sensible Biotechnologies?
FundedIQ lists Miroslav Gasparek (CEO and Co-Founder) at Sensible Biotechnologies.
Where is Sensible Biotechnologies headquartered?
Sensible Biotechnologies is based in Oxford, United Kingdom.
How many employees does Sensible Biotechnologies have?
Sensible Biotechnologies is in the 11-50 employee band.
When was Sensible Biotechnologies founded?
Sensible Biotechnologies was founded in 2021.
About FundedIQ's Sensible Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sensible Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.